TELA Bio (TELA) Restructuring Costs (2024 - 2026)

TELA Bio's Restructuring Costs history runs 3 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Restructuring Costs rose 13.47% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $8.5 million (up 16.34% YoY), while the FY2025 annual figure was $8.2 million, up 14.05% from the prior year.
• Restructuring Costs was $2.1 million for Q1 2026 at TELA Bio, up from $2.1 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $2.2 million in Q2 2025 to a low of $1.8 million in Q2 2024.
• Historically, Restructuring Costs has averaged $2.0 million across 3 years, with a median of $1.9 million in 2025.
• Biggest YoY gain for Restructuring Costs was 21.24% in 2025; the steepest drop was 4.26% in 2025.
• A 3-year view of Restructuring Costs shows it stood at $1.8 million in 2024, then advanced by 13.69% to $2.1 million in 2025, then gained by 2.64% to $2.1 million in 2026.
• The last three Restructuring Costs figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.